Company Description
The backbone of Teva Pharmaceutical Industries is its world-leading generic pharmaceuticals business. Through subsidiary Teva Pharmaceuticals USA,...
Headquarters:
5 Basel StPetah Tikva, 49131, Israel
Key Teva Pharmaceuticals Financials
| Company Type | Public - NASDAQ (GS): TEVA; Tel Aviv: TEVA Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $9,408.0 |
| 2006 Employees | 26,700 |
More Teva Pharmaceuticals Financials (11 pages)
Latest Teva Pharmaceuticals Jobs jobs by Indeed
Rankings
- #291 in FT Global 500
Competition
Competitive Landscape for Pharmaceutical Manufacture and Sale
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs....
Read more about Teva Pharmaceuticals's competition across multiple industries
Top Teva Pharmaceuticals Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Teva Pharmaceuticals Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Eli Hurvitz | Network | E-mail |
| President and CEO | Shlomo Yanai | Network | E-mail |
| VP and CTO | Rodney Kasan | Network | E-mail |
More Teva Pharmaceuticals Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Teva Pharmaceuticals News
- Briefing.com: Hourly In Play (R) - 07:09 ET [Briefing.com] (09 Jul 2008 07:09:00 EDT)
- Briefing.com: Hourly In Play (R) - 06:01 ET [Briefing.com] (09 Jul 2008 06:01:00 EDT)
- Briefing.com: Hourly In Play (R) - 05:01 ET [Briefing.com] (09 Jul 2008 05:01:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.